Zhong Shengjian, Wu Fengfu, Peng Na, Xie Qifeng, Song Jingchun, Li Weiqin
Department of Critical Care Medicine, the 923th Hospital of Joint Logistics Support Forces of PLA, Nanning 530021, Guangxi Zhuang Autonomous Region, China.
Huoshenshan Hospital, Wuhan 430071, Hubei, China.
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Sep;32(9):1135-1138. doi: 10.3760/cma.j.cn121430-20200426-00593.
The coronavirus disease 2019 (COVID-19) has outbroken globally. As an acute infectious disease, COVID-19 has significant impacts on multiple organs and systems throughout the body. Among patients with COVID-19, especially severe and critical cases, a variety of potential risk factors for coagulation dysfunction exist. Furthermore, the coagulation dysfunction of COVID-19 patients was mainly characterized by elevated D-dimer levels. The coagulation dysfunction could directly affect the prognosis of COVID-19 patients and is a major cause of death in patients with severe COVID-19. In this article, the literatures on the basic clinical manifestations, clinical risk factor, mechanism of coagulation dysfunction and evaluation of coagulation function in COVID-19 were reviewed.
2019冠状病毒病(COVID-19)已在全球爆发。作为一种急性传染病,COVID-19对全身多个器官和系统有重大影响。在COVID-19患者中,尤其是重症和危重症患者,存在多种凝血功能障碍的潜在危险因素。此外,COVID-19患者的凝血功能障碍主要表现为D-二聚体水平升高。凝血功能障碍可直接影响COVID-19患者的预后,是重症COVID-19患者死亡的主要原因。本文对COVID-19的基本临床表现、临床危险因素、凝血功能障碍机制及凝血功能评估的文献进行了综述。